Health

Heron Therapeutics

$17.97
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.33 (+1.87%) As of 8:26 PM UTC today

Why Robinhood?

You can buy or sell HRTX and other stocks, options, and ETFs commission-free!

About HRTX

Heron Therapeutics, Inc. Common Stock, also called Heron Therapeutics, is a biotechnology company, which engages in the development of pharmaceutical products for patients suffering from cancer. Its products portfolio include SUSTOL, Cinvanti, HTX-011, and HTX-034. The company was founded in February 1983 and is headquartered in Redwood City, CA. The listed name for HRTX is Heron Therapeutics, Inc. Common Stock.

CEO
Barry D. Quart
Employees
231
Headquarters
San Diego, California
Founded
1983
Market Cap
1.68B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.03M
High Today
$18.08
Low Today
$17.64
Open Price
$17.97
Volume
741.18K
52 Week High
$24.76
52 Week Low
$9.60

Collections

HRTX Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 1, Pre-Market

You May Also Like

CEFA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure